Silke Mainka, M.B.L.-HSG
Member
![Silke Mainka](/sites/default/files/styles/biography_image/public/2024-08/Silke%20Mainka_01003291_Web.jpg?itok=kfAyPaH9)
- Year of birth 1970
- Nationality German
- Place of residence Neukirch, Germany
- Initial appointment 2024
- End of current period 2025
Professional Development
Since 2022 Country and Innovative Medicines Ethics, Risk & Compliance Head / authorized signatory of Novartis Pharma GmbH Novartis, Germany
2018 - 2022 Head Legal, Ethics, Risk & Compliance / authorized signatory of Novartis Pharma GmbH Novartis Oncology, Germany
2017 - 2018 General Counsel Global Nutritional Health Business, Head Legal Export Markets, UK & Ireland Eli Lilly & Company/Elanco Animal Health, USA
2015 - 2017 General Counsel Global Emerging Businesses Eli Lilly & Company/Elanco Animal Health, USA
2015 Head Legal DACH, BeNeLux & Nordics Eli Lilly & Company/Elanco Animal Health, Germany
2013 - 2014 Head Legal & Compliance Germany & Austria Data Privacy Officer Novartis Animal Health, Germany
2012 - 2015 Legal Advisor, Corporate Legal Biopharma / Strategic Alliances & Transaction Boehringer Ingelheim Pharma, Germany
2000 - 2012 Legal Advisor, Trustees & Management Team Vetter Pharma, Germany
Since 1997 Partner and owner, Law Firm Bott, Eber & Mainka / Law Firm Mainka, Germany
1995 Legal Counsel Law Firm Radon & Ishizumi N.Y., USA
Education
2007 - 2009 Master of European and International Business Law University of St. Gallen (HSG), Switzerland
1998 - 1999 Specialist Lawyer Degree for social law German Lawyers' Institute, Germany
1997 Second State Examination in law Regional Court Ravensburg / Higher Regional Court Stuttgart / Law Firm Bongen, Renaud & Partner, Germany
1994 First State Examination in law Eberhard-Karls-University of Tuebingen, Germany
1990 A-levels Montfort-Gymnasium Tettnang, Germany